Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Deutsche Bank Maintains Buy on Bio-Techne, Lowers Price Target to $82

Author: Benzinga Newsdesk | April 18, 2024 08:12am

Deutsche Bank analyst Justin Bowers maintains Bio-Techne (NASDAQ:TECH) with a Buy and lowers the price target from $85 to $82.

Posted In: TECH